Coombs-negative haemolysis in hepatosplenic T-cell lymphoma

BJH - volume 13, issue 8, december 2022

R.L. van der Horst MD, R.L. Römers MD, F. Stifft MD, R.J. Martens MD, M.P. Leers MD, R.J. van Kampen MD


We present to you a Coombs-negative haemolytic anaemia in a patient with a hepatosplenic T-cell lymphoma (HSTL). The underlying mechanism was considered to be due to the massive hypersplenism or a Coombs negative immune-mediated direct cytotoxic mechanism, which has been previously described in patients with HSTL. Our patient was treated with cytostatic therapy consisting of dexamethasone, cytarabin and cisplatin (DHAP), followed by allogenic stem cell transplantation, after which complete remission was achieved.

(BELG J HEMATOL 2022;13(8):316–20)

Read more